Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of Diabetes in Patients Diagnosed With COVID-19
Mohamed Abu‐Farha, Fahd Al‐Mulla, Thangavel Alphonse Thanaraj, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Robust Antibody Levels in Both Diabetic and Non-Diabetic Individuals After BNT162b2 mRNA COVID-19 Vaccination
Hamad Ali, Abdulmohsen Alterki, Sardar Sindhu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 81
Hematological abnormalities and comorbidities are associated with COVID-19 severity among hospitalized patients: Experience from Bangladesh
Md. Ashrafur Rahman, Yeasna Shanjana, Md. Ismail Tushar, et al.
PLoS ONE (2021) Vol. 16, Iss. 7, pp. e0255379-e0255379
Open Access | Times Cited: 67
Diabetes mellitus and COVID-19: Understanding the association in light of current evidence
Saikat Sen, Raja Chakraborty, Pratap Kalita, et al.
World Journal of Clinical Cases (2021) Vol. 9, Iss. 28, pp. 8327-8339
Open Access | Times Cited: 63
Epigenetic regulation of energy metabolism in obesity
Wei Gao, Jiali Liu, Xiang Lü, et al.
Journal of Molecular Cell Biology (2021) Vol. 13, Iss. 7, pp. 480-499
Open Access | Times Cited: 58
Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: A systematic review
Amir Bahador Boroumand, Mahtab Forouhi, Farzaneh Karimi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 55
Acute respiratory distress syndrome heterogeneity and the septic ARDS subgroup
Huikang Xu, Shiying Sheng, Weiwei Luo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27
Epigenetic perspectives associated with COVID-19 infection and related cytokine storm: an updated review
Amit Dey, K. Vaishak, Dikshita Deka, et al.
Infection (2023) Vol. 51, Iss. 6, pp. 1603-1618
Open Access | Times Cited: 23
Nanotechnology as a Shield against COVID-19: Current Advancement and Limitations
Mahendra Rai, Shital Bonde, Alka Yadav, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1224-1224
Open Access | Times Cited: 54
National and regional trends in the prevalence of type 2 diabetes and associated risk factors among Korean adults, 2009–2021
Jiyeon Oh, Soeun Kim, Myeongcheol Lee, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Early Use of Liraglutide for the Treatment of Acute COVID-19 Infection: An Open-Label Single-Center Phase II Safety Study with Biomarker Profiling
Eloara V.M. Ferreira, Rudolf K.F. Oliveira, Reinaldo Salomão, et al.
Infectious Disease Reports (2025) Vol. 17, Iss. 1, pp. 5-5
Open Access
Assessment of serum biomarker changes following the COVID-19 pandemic and vaccination: a cohort study in Sylhet, Bangladesh
Sonam Akther, Fairoz Samiha, Sabrina Amita Sony, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
Insulin Treatment May Increase Adverse Outcomes in Patients With COVID-19 and Diabetes: A Systematic Review and Meta-Analysis
Yan Yang, Zixin Cai, Jingjing Zhang
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 39
Clinical characteristics and outcomes of COVID-19 patients with diabetes mellitus in Kuwait
Abdullah Alshukry, Mohammad Bu Abbas, Yaseen Ali, et al.
Heliyon (2021) Vol. 7, Iss. 4, pp. e06706-e06706
Open Access | Times Cited: 37
ACE2 and FURIN variants are potential predictors of SARS-CoV-2 outcome: A time to implement precision medicine against COVID-19
Fahd Al‐Mulla, Anwar Mohammad, Ashraf Al Madhoun, et al.
Heliyon (2021) Vol. 7, Iss. 2, pp. e06133-e06133
Open Access | Times Cited: 32
Dexamethasone in COVID-19 treatment: Analyzing monotherapy and combination therapy approaches
Seyed Mohammadmahdi Meybodi, Venus Shahabi Rabori, Darya Salkhorde, et al.
Cytokine (2024) Vol. 184, pp. 156794-156794
Closed Access | Times Cited: 4
Outcome and death risk of diabetes patients with Covid-19 receiving pre-hospital and in-hospital metformin therapies
Rodrigo Esaki Tamura, Said Muhammad Said, Leticia Mussin de Freitas, et al.
Diabetology & Metabolic Syndrome (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 30
Tim-3 Expression Causes NK Cell Dysfunction in Type 2 Diabetes Patients
Hui Wang, Kangli Cao, Siyu Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20
The amplification of CNS damage in Alzheimer's disease due to SARS-CoV2 infection
Gerard J. Nuovo, David Suster, Dwitiya Sawant, et al.
Annals of Diagnostic Pathology (2022) Vol. 61, pp. 152057-152057
Open Access | Times Cited: 19
Understanding the mechanism underlying the anti-diabetic effect of dietary component: a focus on gut microbiota
Yuhan Zhao, Mengjie Li, Yanan Wang, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 25, pp. 7378-7398
Closed Access | Times Cited: 18
Susceptibility of Diabetic Patients to COVID-19 Infections: Clinico-Hematological and Complications Analysis
Banan Atwah, Mohammad Shahid Iqbal, Saeed Kabrah, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 561-561
Open Access | Times Cited: 10
Hospitalized COVID‐19 patients with diabetes have an increased risk for pneumonia, intensive care unit requirement, intubation, and death: A cross‐sectional cohort study in Mexico in 2020
Alexander A. Huang, Samuel Y. Huang
Health Science Reports (2023) Vol. 6, Iss. 4
Open Access | Times Cited: 10
Long-Term Persistence of COVID-Induced Hyperglycemia: A Cohort Study
Vrinda Goel, Alpana Raizada, Amitesh Aggarwal, et al.
American Journal of Tropical Medicine and Hygiene (2024) Vol. 110, Iss. 3, pp. 512-517
Open Access | Times Cited: 3
Inter-relação entre COVID-19 e diabetes mellitus: uma revisão sistemática
Felipe Pereira Marinho, Isabella Santos de Loyola, Igor de Oliveira Freire Monteiro, et al.
Research Society and Development (2021) Vol. 10, Iss. 2, pp. e4810212191-e4810212191
Open Access | Times Cited: 19
Poor Metabolic Health Increases COVID-19-Related Mortality in the UK Biobank Sample
Filip Morys, Alain Dagher
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 17
Research Status of the Safety and Efficacy of Mesenchymal Stem Cells in the Treatment of COVID-19-Related Pneumonia: A Systematic Review and Meta-Analysis
Junwu Wang, Pengzhi Shi, Dong Chen, et al.
Stem Cells and Development (2021) Vol. 30, Iss. 19, pp. 947-969
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top